ARTICLE | Management Tracks
Vir names Jason O’Byrne CFO
Plus: Maslowski to become CEO of Forge as Miller steps down, and updates from Sofinnova Partners, Abingworth, PATH and more
September 10, 2024 11:38 PM UTC
Jason O’Byrne will become EVP and CFO of Vir Biotechnology Inc. (NASDAQ:VIR) on Oct. 2. O’Byrne was CFO of Caribou Biosciences Inc. (NASDAQ:CRBU).
CEO Timothy Miller will step down from Forge Biologics Inc., which named Chief Commercial Officer John Maslowski president, CEO and a director, effective Oct. 1. Miller co-founded Forge, part of Ajinomoto Co. Inc. (Tokyo:2802), in 2020. ...